IRIS
DE LUCA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.624
EU - Europa 3.268
AS - Asia 3.144
SA - Sud America 1.023
Continente sconosciuto - Info sul continente non disponibili 596
AF - Africa 90
OC - Oceania 4
Totale 11.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.420
RU - Federazione Russa 2.264
SG - Singapore 1.306
BR - Brasile 840
CN - Cina 621
HK - Hong Kong 527
IT - Italia 456
BD - Bangladesh 183
VN - Vietnam 154
FR - Francia 122
DE - Germania 93
IN - India 78
CA - Canada 74
IE - Irlanda 65
MX - Messico 64
GB - Regno Unito 59
AR - Argentina 58
AT - Austria 37
NL - Olanda 37
ZA - Sudafrica 35
IQ - Iraq 33
EC - Ecuador 32
TR - Turchia 30
CO - Colombia 27
PK - Pakistan 24
FI - Finlandia 23
ID - Indonesia 23
SE - Svezia 21
VE - Venezuela 19
CL - Cile 18
MY - Malesia 18
UA - Ucraina 18
UZ - Uzbekistan 18
SA - Arabia Saudita 17
ES - Italia 16
PH - Filippine 16
JP - Giappone 15
PL - Polonia 15
CR - Costa Rica 14
JM - Giamaica 14
MA - Marocco 12
PE - Perù 12
JO - Giordania 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CI - Costa d'Avorio 8
IL - Israele 8
PY - Paraguay 8
SV - El Salvador 8
HN - Honduras 7
KE - Kenya 7
TN - Tunisia 7
EG - Egitto 6
NI - Nicaragua 6
DO - Repubblica Dominicana 5
LB - Libano 5
LT - Lituania 5
UY - Uruguay 5
AU - Australia 4
BG - Bulgaria 4
CH - Svizzera 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
KG - Kirghizistan 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KZ - Kazakistan 2
LV - Lettonia 2
MT - Malta 2
PS - Palestinian Territory 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HT - Haiti 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
Totale 11.138
Salva come PNG Salva come JPEG
Città #
Ashburn 810
Moscow 736
Singapore 546
Hong Kong 524
San Jose 420
Dallas 333
Council Bluffs 260
Beijing 130
Los Angeles 113
The Dalles 108
Santa Clara 93
Lauterbourg 81
Columbus 78
New York 70
Dublin 64
Messina 56
Ho Chi Minh City 54
Buffalo 53
São Paulo 52
Catania 40
Hanoi 40
Redondo Beach 39
Mexico City 37
Frankfurt am Main 33
Rio de Janeiro 33
Paternò 30
Belo Horizonte 27
Orem 27
Hyderabad 26
Munich 26
Guangzhou 25
Tianjin 24
Amsterdam 23
Shanghai 23
Vienna 23
Boardman 22
Milan 22
Phoenix 22
Chicago 21
Johannesburg 21
Rome 20
Atlanta 19
Brooklyn 19
Turin 19
Montreal 18
Dhaka 16
Nuremberg 16
Porto Alegre 16
Tashkent 15
Chennai 14
Manchester 14
Tokyo 14
Toronto 14
Houston 13
Philadelphia 13
San Francisco 13
Guayaquil 12
Quito 12
San José 12
Warsaw 12
Caxias do Sul 11
Chandler 11
Curitiba 11
Denver 11
Shenzhen 11
Kingston 10
Kuala Lumpur 10
London 10
Ribeirão Preto 10
Amman 9
Baghdad 9
Boston 9
Campinas 9
Charlotte 9
Haiphong 9
Helsinki 9
Medellín 9
Naples 9
Seattle 9
Stockholm 9
Abidjan 8
Ankara 8
Baku 8
Cincinnati 8
Prineville 8
Chongqing 7
City of London 7
Franca 7
Goiânia 7
Istanbul 7
Lappeenranta 7
Lima 7
New Delhi 7
Riyadh 7
San Salvador 7
Santo André 7
Springfield 7
Washington 7
Biên Hòa 6
Caracas 6
Totale 5.803
Salva come PNG Salva come JPEG
Nome #
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 295
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 241
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 176
Immature platelet fraction and the extent of coronary artery disease: a single centre study 155
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 155
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 147
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 138
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 130
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 117
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 112
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 108
A meta-analytic overview of thrombectomy during primary angioplasty 106
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 106
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 103
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 95
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 94
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 92
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 91
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 89
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 89
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 88
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 88
Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention 87
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 87
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 86
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 86
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 85
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 85
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 85
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 84
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 84
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 84
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 84
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 83
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 83
Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention 83
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 83
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 82
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 82
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 81
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 81
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 80
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 80
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 80
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 79
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 79
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 78
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 78
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 78
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 78
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 78
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 78
An unusual case of ECG ST-segment elevation 77
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 77
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 77
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 77
Immature platelet fraction and the extent of coronary artery disease: A single centre study 77
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 77
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 76
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 76
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 75
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 75
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry 75
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 75
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease' 75
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 75
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 74
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 74
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 74
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 74
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: A patient-level meta-analysis of randomized trials 74
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 74
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 73
Adjunctive antithrombotic therapy during Primary PCI 73
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 73
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial 73
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 72
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 71
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 70
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers 70
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 70
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 69
Switching from clopidogrel to prasugrel in patients having coronary stent implantation 69
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 68
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 68
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 67
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 67
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 66
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 66
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 66
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 66
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 65
Clinical efficacy and safety of intracoronary vs. intravenous abciximab administration in STEMI patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials 64
Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography 64
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 63
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale 62
Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials 62
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 62
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 62
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 62
Totale 8.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023708 2 3 1 4 4 5 3 4 11 473 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/20252.566 21 27 28 176 142 106 90 338 621 152 321 544
2025/20266.999 310 478 454 327 493 1.269 977 770 786 416 370 349
2026/20271.059 589 470 0 0 0 0 0 0 0 0 0 0
Totale 11.749